On the public citation graph

In Silico Design of Beta‐Secretase Inhibitors in Alzheimer's Disease

https://doi.org/10.1111/cbdd.12492
0 signed · 37 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/elps.1150181505openalex-snapshot
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
inferredcites →https://doi.org/10.1016/j.bmcl.2008.04.011openalex-snapshot
In silico multi-filter screening approaches for developing novel β-secretase inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2010.07.140openalex-snapshot
Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
inferredcites →https://doi.org/10.1016/j.bmcl.2010.08.111openalex-snapshot
Molecular docking and structure–activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors
inferredcites →https://doi.org/10.1016/j.ejphar.2008.01.049openalex-snapshot
The potential role of nutritional components in the management of Alzheimer's Disease
inferredcites →https://doi.org/10.1016/j.nurt.2008.05.007openalex-snapshot
β-Secretase as a Therapeutic Target for Alzheimer's Disease
inferredcites →https://doi.org/10.1016/j.str.2005.06.015openalex-snapshot
Functional Plasticity in the Substrate Binding Site of β-Secretase
inferredcites →https://doi.org/10.1021/bi020151+openalex-snapshot
X-ray Structures of Torpedo californica Acetylcholinesterase Complexed with (+)-Huperzine A and (−)-Huperzine B: Structural Evidence for an Active Site Rearrangement,
inferredcites →https://doi.org/10.1021/ci3001277openalex-snapshot
ZINC: A Free Tool to Discover Chemistry for Biology
inferredcites →https://doi.org/10.1021/jm000934yopenalex-snapshot
GRID/CPCA: A New Computational Tool To Design Selective Ligands
inferredcites →https://doi.org/10.1021/jm049133bopenalex-snapshot
Virtual Screening for β-Secretase (BACE1) Inhibitors Reveals the Importance of Protonation States at Asp32 and Asp228
inferredcites →https://doi.org/10.1038/nm1784openalex-snapshot
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase
inferredcites →https://doi.org/10.1038/nrd2597openalex-snapshot
Inhibiting β-secretase where it matters
inferredcites →https://doi.org/10.1073/pnas.0709788105openalex-snapshot
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
inferredcites →https://doi.org/10.1073/pnas.1017033108openalex-snapshot
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
inferredcites →https://doi.org/10.1093/nar/28.1.235openalex-snapshot
The Protein Data Bank
inferredcites →https://doi.org/10.1093/nar/gkq300openalex-snapshot
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
inferredcites →https://doi.org/10.1107/s0108768102003890openalex-snapshot
The Cambridge Structural Database: a quarter of a million crystal structures and rising
inferredcites →https://doi.org/10.1111/cbdd.12016openalex-snapshot
Synthesis, in vitro Biological Evaluation and Molecular Docking Studies of Benzimidamides as Potential BACE1 Inhibitors
inferredcites →https://doi.org/10.1111/j.1471-4159.2011.07476.xopenalex-snapshot
Developing β‐secretase inhibitors for treatment of Alzheimer’s disease
inferredcites →https://doi.org/10.1111/j.1747-0285.2011.01087.xopenalex-snapshot
Sequential Virtual Screening Approach to the Identification of Small Organic Molecules as Potential BACE‐1 Inhibitors
inferredcites →https://doi.org/10.1111/j.1747-0285.2012.01367.xopenalex-snapshot
The Discovery of Novel β‐Secretase Inhibitors: Pharmacophore Modeling, Virtual Screening, and Docking Studies
inferredcites →https://doi.org/10.1177/096032719101000405openalex-snapshot
Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System
inferredcites →https://doi.org/10.1186/1471-2105-12-s1-s28openalex-snapshot
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
inferredcites →https://doi.org/10.1186/1471-2105-12-s14-s4openalex-snapshot
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
inferredcites →https://doi.org/10.2174/1573407211309010003openalex-snapshot
Structure and Ligand Based Rational Drug Design for Bace-1 Inhibitors

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/ijch.201600073openalex-snapshot
Generation of Amyloid‐β Peptides by γ‐Secretase
inferred← citeshttps://doi.org/10.1007/7653_2018_25openalex-snapshot
Computational Design of Multitarget Drugs Against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-46545-1_20openalex-snapshot
In Silico Design of Acetylcholinesterase and Glycogen Synthase Kinase-3β Multi-target Inhibitors
inferred← citeshttps://doi.org/10.1007/s12195-015-0421-8openalex-snapshot
Per-Residue Energy Footprints-Based Pharmacophore Modeling as an Enhanced In Silico Approach in Drug Discovery: A Case Study on the Identification of Novel β-Secretase1 (BACE1) Inhibitors as Anti-Alzheimer Agents
inferred← citeshttps://doi.org/10.1007/s42452-026-08245-5openalex-snapshot
Combining AI design and molecular dynamics to disrupt amyloid aggregation in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/j.bcab.2025.103559openalex-snapshot
Protease inhibitor from Streptomyces pulveraceus strain VITSSAB as a potential therapeutic agent against BACE1 in Alzheimer's disease: A molecular docking and dynamics simulations study
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.01.030openalex-snapshot
Indazolylketones as new multitarget cannabinoid drugs
inferred← citeshttps://doi.org/10.2174/1570159x15666170823095628openalex-snapshot
In Silico Studies in Drug Research Against Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.2174/1570180816666191029142640openalex-snapshot
Understanding the Binding Mechanism of Antagonist (AZD3293) Against BACE-1: Molecular Insights into Alzheimer’s Drug Discovery
inferred← citeshttps://doi.org/10.3390/ph16121645openalex-snapshot
Identification of Potential Multitarget Compounds against Alzheimer’s Disease through Pharmacophore-Based Virtual Screening
inferred← citeshttps://doi.org/10.3390/ph16121657openalex-snapshot
Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.